Literature DB >> 8405082

Role of endothelium-derived relaxing factor on coronary blood flow regulation in the dog.

R Domenech1, P Macho, M Penna, H Schwarze, J P Huidobro-Toro, A Thumala.   

Abstract

The endothelium plays a key role in the regulation of vasoreactivity. To assess its importance on coronary flow regulation, we studied the participation of endothelium-derived relaxing factor-nitric oxide (EDRF-NO) on coronary reactive hyperemia and on the hyperemia that occurs secondary to an increase in myocardial oxygen consumption. In 15 dogs, the reactive hyperemic response decreased substantially after inhibition of EDRF-NO synthesis with N-omega-nitro-L-arginine (P < 0.01). In contrast, the hyperemia secondary to an increase in myocardial oxygen consumption, characterized by a linear correlation between myocardial oxygen consumption and coronary flow, did not change significantly after inhibition of EDRF-NO production (regression analysis, P > 0.1). Thus EDRF-NO synthesis by the endothelium is an important mechanism mediating the reactive hyperemic response but it does not seem to be essential for the metabolic regulation of coronary vascular resistance during hyperemia induced by an increased metabolic demand on the myocardium.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405082     DOI: 10.1016/0014-2999(93)90504-b

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  1 in total

1.  Low dose calcium-antagonism compensates for impaired myocardial blood supply resulting from deficient nitric oxide synthesis.

Authors:  J Zanzinger; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.